Medical Science News

RSS

Neuralstem announces treatment of first ALS patient with spinal cord stem cells

Neuralstem, Inc. announced that the first ALS patient was treated with its spinal cord stem cells yesterday at the Emory ALS Center at Emory University, in Atlanta, GA. A total of up to 18 patients is planned to be treated in this first U.S. clinical trial to evaluate human neural stem cells for the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease). ALS affects roughly 30,000 people in the U.S., with about 5,600 new diagnoses per year, according to the ALS Association.

21 Jan 2010

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

Applied Biosystems, part of Life Technologies Corporation today announced that its AmpFℓSTR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic comparison and exchange of DNA profiles between participating local, county, state, and federal law enforcement agencies and forensic laboratories.

21 Jan 2010

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell and tissue storage/transport media and CryoStor™ cryopreservation media.

21 Jan 2010

Latest interdisciplinary project from Wiley-Blackwell

Cognitive Science represents the exploration of the human mind in the hope of answering some of humanity's oldest questions, from the origin of thought to the nature of knowledge. Today cognitive scientists link these ancient questions to the newest emerging fields of research in various areas, an approach epitomized by WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell.

21 Jan 2010

WIREs Cognitive Science explores the rise of neurolaw

What if a jury could decide a man's guilt through mind reading? What if reading a defendant's memory could betray their guilt? And what constitutes 'intent' to commit murder? These are just some of the issues debated and reviewed in the inaugural issue of WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell, which for registered institutions will be free for the first two years.

21 Jan 2010

Study demonstrates BTG2 gene is crucial for neurogenesis and contextual memory function

The birth of new neurons, a process called neurogenesis, is continuously occurring in the brain, not only during development but also during adulthood within two specialized areas, the hippocampus and the subventricular zone.

21 Jan 2010

Showing scan images to motivate healthy behaviors in patients provides mixed results

Can showing patients ultrasounds and X-rays of their bodies to point out existing health damage make patients change their risky behavior?

21 Jan 2010

Study lays groundwork to develop new treatments for cardiovascular disease and other conditions

In a significant step toward restoring healthy blood circulation to treat a variety of diseases, a team of scientists at Weill Cornell Medical College has developed a new technique and described a novel mechanism for turning human embryonic and pluripotent stem cells into plentiful, functional endothelial cells, which are critical to the formation of blood vessels.

21 Jan 2010

COTI's novel small molecule effective against pancreatic cancer in animal model

Critical Outcome Technologies Inc. announced more positive results today from animal experiments carried out at a prominent Canadian cancer research facility. This new series of experiments adds to the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in combination with current first line therapies, as well as low toxicity in several different animal models of human cancers.

21 Jan 2010

Older adults may be wiser decision-makers compared to younger counterparts

A new study has found promising evidence that the older brain's weakened ability to filter out irrelevant information may actually give aging adults a memory advantage over their younger counterparts.

21 Jan 2010

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals.

21 Jan 2010

Researchers explain how HSV dismantles host's defense systems

A viral infection is like an uninvited, tenacious houseguest in the cell, using a range of tricks to prevent its eviction. Researchers at the Salk Institute for Biological Studies have identified one of the key proteins allowing herpes simplex virus (HSV) DNA to fly under the radar of their hosts' involuntary hospitality.

21 Jan 2010

ChromoCure's aneuploidy theory of cancer further validated

ChromoCure, Inc. -- The Company announces that its long-held theory of cancer, aneuploidy, has been further validated by a study published in the January 15, 2010 issue of Cancer Research (Volume 70, Issue 2).

21 Jan 2010

Mouse sperm can discriminate between its brethren and competing sperm, says study

Some mouse sperm can discriminate between its brethren and competing sperm from other males, clustering with its closest relatives to swim faster in the race to the egg. But this sort of cooperation appears to be present only in certain promiscuous species, where it affords an individual's sperm a competitive advantage over that of other males.

21 Jan 2010

Quorum sensing offers a dynamic approach to increase sensitivity to external signals

Researchers at UC San Diego who last year genetically engineered bacteria to keep track of time by turning on and off fluorescent proteins within their cells have taken another step toward the construction of a programmable genetic sensor. The scientists recently synchronized these bacterial "genetic clocks" to blink in unison and engineered the bacterial genes to alter their blinking rates when environmental conditions change.

21 Jan 2010

New research reveals grid cells in human brain provide a cognitive, spatial map

'Grid cells' that act like a spatial map in the brain have been identified for the first time in humans, according to new research by UCL scientists which may help to explain how we create internal maps of new environments.

21 Jan 2010

Study indicates size of brain structures may predict performance and learning rates

Researchers can predict your performance on a video game simply by measuring the volume of specific structures in your brain, a multi-institutional team reports this week.

21 Jan 2010

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.

21 Jan 2010

Discovery of new class of compounds may help fight hepatitis C

Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus’s propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.

21 Jan 2010

Life sciences and healthcare segments support nanotech venture capital investments

The heyday for nanotech venture capital (VC) likely saw its peak in 2008, when overall investment reached $1.4 billion. Last year, the sector raised only $792 million, signifying a 42% decline from 2008. But while overall nano VC backing is down, it's not out, according to a new report from Lux Research.

21 Jan 2010

Medical Science News

Neuralstem announces treatment of first ALS patient with spinal cord stem cells

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

Latest interdisciplinary project from Wiley-Blackwell

WIREs Cognitive Science explores the rise of neurolaw

Study demonstrates BTG2 gene is crucial for neurogenesis and contextual memory function

Showing scan images to motivate healthy behaviors in patients provides mixed results

Study lays groundwork to develop new treatments for cardiovascular disease and other conditions

COTI's novel small molecule effective against pancreatic cancer in animal model

Older adults may be wiser decision-makers compared to younger counterparts

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

Researchers explain how HSV dismantles host's defense systems

ChromoCure's aneuploidy theory of cancer further validated

Mouse sperm can discriminate between its brethren and competing sperm, says study

Quorum sensing offers a dynamic approach to increase sensitivity to external signals

New research reveals grid cells in human brain provide a cognitive, spatial map

Study indicates size of brain structures may predict performance and learning rates

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Discovery of new class of compounds may help fight hepatitis C

Life sciences and healthcare segments support nanotech venture capital investments

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News